Sana Biotechnology, Inc.
SANA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $376 | $794 | $744 | $2,576 |
| - Cash | $128 | $134 | $177 | $253 |
| + Debt | $94 | $104 | $108 | $111 |
| Enterprise Value | $343 | $764 | $675 | $2,434 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$255 | -$269 | -$257 | -$346 |
| % Margin | – | – | – | – |
| Net Income | -$267 | -$283 | -$269 | -$356 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.16 | -1.46 | -1.43 | -2.14 |
| % Growth | 20.5% | -2.1% | 33.2% | – |
| Operating Cash Flow | -$223 | -$254 | -$290 | -$251 |
| Capital Expenditures | -$33 | -$20 | -$21 | -$30 |
| Free Cash Flow | -$257 | -$274 | -$311 | -$281 |